| J2350 | Injection, ocrelizumab, 1 mg | 8,700 | $50 | $400.2K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,610 | $30 | $93.9K |
| J0897 | Injection, denosumab, 1 mg | 3,780 | $20 | $68K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 4,750 | $10 | $47.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 190 | $110 | $19.4K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 100 | $60 | $6.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 110 | $50 | $5.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 50 | $100 | $4.8K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 120 | $20 | $2.8K |
| 45380 | The provider examines the rectum and colon using a flexible colonoscope, a tubular instrument with a light source and camera, to look for the cause of a patient's symptoms, which may include… | 20 | $120 | $2K |